ARS Pharmaceuticals, Inc. (SPRY) Gross margin
ARS Pharmaceuticals, Inc. (SPRY) gross margin by fiscal year — reported gross profit divided by reported revenue.
100.0%FY2024
| Fiscal year | Value | YoY |
|---|---|---|
| FY2024 | 100.0% | — |
Gross margin = reported gross profit ÷ reported revenue for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice